PDC

Plastic Design Corporation, trading under the name PDC, specializes in high-performance micro injection molding for medical device and life sciences sectors, delivering precision-engineered components to enhance functionality in critical healthcare applications. Plastic Design Corporation trading under the name PDC, founded in 1991 and headquartered in Scottsdale, US, focuses on micro injection molding for the medical industry. In December 2021, Vance Street Capital acquired Plastic Design Corporation. Financial terms were not disclosed.

In 2025, Vance Street Capital announce that Plastic Design Company, Resenex, and Injectech would combine to now operate under the VSC Medical Molding Platform. PDC specializes in high-performance micro injection molding and value-added assembly for the medical device and life sciences sectors. The company's core offerings include precision injection molded components derived from complex materials such as PEEK, PEBA, and COP/COC thermoplastics. These products are designed to enhance the functionality and precision required in critical applications such as drug delivery systems and advanced biopsy tools, enabling healthcare providers to deliver accurate medication dosages and improve diagnostic capabilities.

PDC serves a diverse client base, including original equipment manufacturers (OEMs) and contract manufacturers in various geographical markets, including North America, Europe, and parts of Asia. The company operates under an ISO 13485:2016 certified quality system, ensuring that its solutions meet the stringent regulatory requirements of the medical industry. Revenue generation at PDC is primarily driven through B2B transactions, where the company partners with OEMs and contract manufacturers to provide tailored injection molding solutions. The company’s business model focuses on long-term partnerships, often involving contracts for ongoing supply or project-based engagements, allowing for flexibility and scalability in meeting client demands.

While specific pricing plans are not disclosed, the transactions typically encompass bulk orders of precision components, with clients engaging PDC for both prototype development and high-volume production. This transactional structure supports a diverse product line that caters to the medical device, diagnostics, and biotechnology markets, reflecting PDC’s commitment to innovation and quality in precision engineering.